Experiments with HFD-fed β-klothoCamk2a mice showed that β-klotho in the hypothalamus is needed to recapitulate the majority of the beneficial effects of FGF21 treatment during obesity. This evidence concerns the gene KLB and obesity due to melanocortin 4 receptor deficiency.